NCT04203914View on ClinicalTrials.gov

Short Term Effect of Empagliflozin in Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

May 30, 2017

Study Completion Date

September 30, 2017

Conditions
Hypertension
Interventions
DRUG

Empagliflozin Tablets

Add-on 25mg once daily

Trial Locations (2)

Unknown

National Obesity Centre, Yaounde Central Hospital, Yaoundé

Yaounde Central Hospital, Yaoundé

All Listed Sponsors
lead

Yaounde Central Hospital

OTHER_GOV

NCT04203914 - Short Term Effect of Empagliflozin in Hypertension | Biotech Hunter | Biotech Hunter